Login

Christoph Vilanek of Freenet AG speaks at the 25 Years MCI event, while Thierry Bernard, CEO of QIAGEN N.V., participates in the Distinguished Guest Livetalk. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek, CEO of Freenet

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
St George Mining Discovers Large Nickel Sulfide Target at Mount Alexander
00:10:00
Silver One: Revitalizing Historic Silver Mines and Exploring New Opportunities
00:10:00
Q1 2022 Market Review: Impact of Geopolitical Events, Inflation, and Investment Strategies
00:10:00
Skyfii Ltd CEO Wayne Arthur tells Proactive about securing several new contract wins in the global airport sector.
00:10:00
How to Stay Calm During Market Sell-Offs: Tips from a Wealth Management Advisor
00:10:00
Business is not always a easy way to make money|Bruce Hamilton,General Partner, Everybody Ventures
00:10:00
BDO's Global CEO Keith Farlinger Discusses the Power of Purpose and People | Keith Farlinger, CEO , BDO International.
00:10:00
John Hairston, president and CEO of Hancock Whitney, appears on 'The Exchange' to discuss the opening of the bank's first San Antonio branch.
00:10:00
Alma Media CEO Kai Telanne Highlights Success in Digital Business Growth at Capital Market Day | Kai Telanne, CEO, Alma Media Oyj.
00:10:00
Rafaela Resources: Driving Forward with Critical Metals Focus
00:10:00
Zuora Subscribed 2017 | Tien Tzuo, CEO, Zuora IncZUO:NYQ
00:10:00
Maximize Your Investment Returns with Bernard Wealth Management

© 2026 Nehu